OREX

Orexigen Therapeutics, Inc. News Headlines

$4.39
*  
0.01
0.23%
Get OREX Alerts
*Delayed - data as of Oct. 24, 2014  -  Find a broker to begin trading OREX now
Exchange: NASDAQ
Industry: Health Care
Community Rating:
 
 
Symbol List Views
FlashQuotes InfoQuotes
Stock Details
Summary Quote Real-Time Quote After Hours Quote Pre-market Quote Historical Quote Option Chain
CHARTS
Basic Chart Interactive Chart
COMPANY NEWS
Company Headlines Press Releases Market Stream
STOCK ANALYSIS
Analyst Research Guru Analysis Stock Report Competitors Stock Consultant Stock Comparison
FUNDAMENTALS
Call Transcripts Annual Report Income Statement Revenue/EPS SEC Filings Short Interest Dividend History
HOLDINGS
Ownership Summary Institutional Holdings Insiders
(SEC Form 4)
 Save stocks for next time
Viewing
Filtered By
Ordered By
Assessing Arena Pharmaceutical Belviq Sales And The Impact Of TV Ads
10/22/2014 9:16:00 AM - Seeking Alpha


Arena Investors Need To Watch Contrave Launch Closely
10/22/2014 9:08:00 AM - Seeking Alpha


Could Arena Pharmaceuticals Inc. Be Running Out of Money?
10/22/2014 8:20:02 AM - Motley Fool


NBIX For The Long Haul, RegeneRx Catches Investors' Eyes, NewLink Inks New Deal
10/20/2014 11:47:00 PM - RTT News


Orexigen Launches Contrave - Watch For Traction
10/20/2014 2:01:00 PM - Seeking Alpha


Hasbro Adj. Earnings Top Estimates
10/20/2014 7:59:00 AM - RTT News


Are People Too Concerned About Orexigen's Contrave Label?
10/19/2014 12:33:00 PM - Seeking Alpha


Belviq Sales Dip: What To Watch For Ahead
10/17/2014 1:13:00 PM - Seeking Alpha


Orexigen Up on $100M Milestone Payment from Takeda - Analyst Blog
10/16/2014 1:37:00 PM - Zacks.com


What To Watch For As Orexigen's Launch Approaches
10/16/2014 8:05:00 AM - Seeking Alpha


Belviq Sales Rise Almost 5% Week Over Week
10/10/2014 12:39:00 PM - Seeking Alpha


3 Biotech Stocks Near 52-Week Lows Worth Buying
10/8/2014 8:35:02 AM - Motley Fool


Orexigen On A Tear - In The Wrong Direction
10/7/2014 1:10:00 AM - Seeking Alpha


Is VIVUS Inc. a Short Sell?
10/4/2014 1:45:02 PM - Motley Fool


Premature Combination Use Of Belviq And Phentermine Is A Risk
9/28/2014 9:27:00 AM - Seeking Alpha


Not Even a Weight Loss Drug Could Stop Orexigen Therapeutics, Inc. From Dropping 20% in 2014
9/25/2014 12:03:01 PM - Motley Fool


New 52-Week Low Could Prompt More Insider Buying At OREX
9/22/2014 1:25:03 PM - BNK Invest


Belviq Sales Recover From Holiday Dip
9/21/2014 5:06:00 PM - Seeking Alpha


It Takes Less Than 15 Minutes To Buy VVUS Shares!
9/19/2014 8:51:00 AM - Seeking Alpha


Why VIVUS, Inc. Is Today's Best Biotech Stock
9/18/2014 1:26:33 PM - Motley Fool


Biotech Stock Roundup: Avanir Soars on Phase II Data, Orexigen's Contrave Approved - Analyst Blog
9/17/2014 3:00:00 PM - Zacks.com


Orexigen Therapeutics Wins Contrave Approval But Investors Should Stay Away
9/16/2014 2:01:00 PM - Seeking Alpha


InsiderInsights.com Daily Round Up 9/15/14: Tallgrass Energy Partners, Mercer, Republic Services, Armada Hoffler Properties
9/16/2014 12:57:00 PM - Seeking Alpha


Orexigen Falls After Approval - Why?
9/15/2014 2:25:00 PM - Seeking Alpha


Arena And Vivus Ruined The FDA Approval Run Up For Orexigen
9/13/2014 8:02:00 PM - Seeking Alpha